U.S. Medical Equipment Stock News

NYSE:VNO
NYSE:VNOOffice REITs

Is Vornado Realty Trust (VNO) Undervalued As Revenue Rose But Earnings Fell?

Vornado Realty Trust (VNO) just released its second quarter and six month 2026 results, giving you fresh data on sales, revenue and profits that can reshape expectations around this New York focused real estate investment trust. See our latest analysis for Vornado Realty Trust. Vornado Realty Trust's latest earnings release and recent preferred dividend declaration have come on the back of a strong 90 day share price return of 27.26% and an 18.09% year to date share price return. The 3 year...
NYSE:COUR
NYSE:COURConsumer Services

Coursera Stock And 2 EdTech Names Linked To College Merger Pressure

College mergers are speeding up as weaker universities strain under falling enrollments, steep tuition discounts, and rising costs, while a smaller pool of students pressures the old campus model. That disruption creates room for platforms that help institutions cut costs, reach global learners, or pivot online. This article unpacks the story behind these shifts and highlights 3 EdTech and online learning stocks that are closely connected to this wave of consolidation. The stocks covered...
NasdaqGS:PATK
NasdaqGS:PATKAuto Components

Patrick Industries (PATK) Completes Buyback As Earnings Rise On Flat Sales Is Its Strategy Shifting?

In the past quarter ended June 28, 2026, Patrick Industries reported second-quarter sales of US$1,041.7 million, with net income rising to US$43.42 million and diluted earnings per share from continuing operations increasing to US$1.28, while also completing a multi-year buyback totaling 5,365,398 shares for US$301.58 million. Despite slightly lower year-over-year sales for both the quarter and first half, the combination of higher earnings and substantial share repurchases highlights...
NasdaqGS:PRVA
NasdaqGS:PRVAHealthcare

Privia Health Group (PRVA) Is Down 5.2% After Q2 Beat And Higher 2026 Outlook - What's Changed

In August 2026, Privia Health Group, Inc. reported second-quarter 2026 results showing sales of US$632.63 million and net income of US$9.05 million, alongside higher earnings per share than a year earlier. The company also indicated that full-year 2026 GAAP revenue should land at the high end of its prior US$2.35 billion to US$2.45 billion guidance range, highlighting stronger-than-previously-expected top-line momentum. Against this backdrop of quarterly revenue growth and a higher full-year...
NasdaqGS:PTEN
NasdaqGS:PTENEnergy Services

Patterson UTI Energy (PTEN) Could Be 25% Undervalued Following ESOP Shelf Filing

Patterson-UTI Energy (PTEN) filed a shelf registration for up to US$296.8m of common stock tied to an employee stock ownership plan soon after reporting second quarter results that again showed a net loss. See our latest analysis for Patterson-UTI Energy. After a sharp year to date share price return of 52.55% and a 1 year total shareholder return of 90.80%, Patterson-UTI Energy has seen momentum cool in recent weeks, with the share price down 5.82% over 7 days as investors weigh the ESOP...
NasdaqGS:TRS
NasdaqGS:TRSPackaging

Is TriMas (TRS) Undervalued On Earnings And Buybacks?

TriMas earnings and buyback update TriMas (TRS) has drawn investor attention after releasing its second quarter and year to date 2026 results, alongside an update on its long running share repurchase program. The company reported second quarter sales of US$174.58 million compared with US$171.75 million a year earlier, while net income for the quarter was US$13.37 million compared with US$16.72 million in the prior year period. For the six months to June 30, 2026, TriMas reported sales of...
NYSE:CRK
NYSE:CRKOil and Gas

Did Haynesville Output Gains and Pinnacle Stake Sale Just Shift Comstock Resources' (CRK) Investment Narrative?

In late July 2026, Comstock Resources, Inc. reported second-quarter results showing revenue of US$353.28 million and net income of US$8.77 million, alongside slightly higher total production driven by increased natural gas volumes despite lower oil output. At the same time, the company highlighted a production uplift tied to accelerated Haynesville drilling and completed a significant midstream equity sale in Pinnacle Gas Services to Sixth Street, using proceeds to retire Pinnacle debt and...
NYSE:MBC
NYSE:MBCBuilding

MasterBrand (MBC) Could Be 75% Undervalued After Earnings And New 2026 Sales Guidance

How the latest earnings event shapes the MasterBrand story MasterBrand (MBC) just reported second quarter 2026 results that paired higher sales with a shift to net loss, while also issuing fresh net sales guidance for the second half of the year. This combination of earnings data and guidance gives you a current snapshot of how the residential cabinets business is tracking and what management expects for the rest of 2026. See our latest analysis for MasterBrand. The latest earnings release...
NYSE:WMK
NYSE:WMKConsumer Retailing

How Stronger First-Half Profitability Trends Will Impact Weis Markets (WMK) Investors

In early August 2026, Weis Markets, Inc. reported past second-quarter results showing sales of US$1,270.86 million and revenue of US$1,275.31 million, with net income of US$22.86 million and basic earnings per share from continuing operations of US$0.92, all compared with the prior year period. For the first half of the year ended June 27, 2026, the company’s higher sales and revenue were accompanied by increased net income of US$50.71 million and basic earnings per share from continuing...
NasdaqGS:ROCK
NasdaqGS:ROCKBuilding

Does Gibraltar Industries (ROCK) Balancing Q2 Margin Pressure With Confident 2026 Guidance Reveal Management’s Priorities?

In the past week, Gibraltar Industries, Inc. reported second-quarter 2026 results showing sales rising to US$509.55 million from US$309.52 million a year earlier, while net income fell to US$8.19 million from US$26 million and earnings per share weakened on both a quarterly and year-to-date basis. At the same time, the company reiterated its full-year 2026 guidance, projecting consolidated net sales of US$1.76 billion to US$1.83 billion and GAAP diluted EPS of US$2.40 to US$2.80,...
NasdaqGS:BAND
NasdaqGS:BANDTelecom

Bandwidth (BAND) Is Up 27.6% After Raising 2026 Revenue Guidance and Returning More Capital

In late July 2026, Bandwidth Inc. reported second‑quarter 2026 results showing year‑over‑year sales growth to US$219.9 million and a move to US$2.39 million in net income, raised full‑year 2026 revenue guidance to US$900 million–US$910 million, amended its credit agreement to increase permitted restricted payments, continued share repurchases, and announced the planned year‑end retirement of General Counsel and Secretary R. Brandon Asbill. A key insight is that Bandwidth is pairing improved...
NYSE:EG
NYSE:EGInsurance

The Bull Case For Everest Group (EG) Could Change Following Q2 Beat And Annapurna Re Launch – Learn Why

In the past week, Everest Group, Ltd. filed a US$300.72 million shelf registration for 812,000 common shares related to an ESOP offering, alongside reporting second-quarter 2026 revenue of US$3.96 billion and net income of US$559 million. These capital moves, together with ongoing share repurchases under a long-running buyback and the launch of Annapurna Re, underline Everest’s emphasis on flexible capital management and underwriting-focused earnings. We’ll now examine how the strong...
NasdaqGM:CMRC
NasdaqGM:CMRCIT

Commerce.com (CMRC) Returns To Profit As Lower Guidance Keeps Fair Value In Focus

Commerce.com (CMRC) is back in focus after a mixed set of August 6 updates. The company reported a return to quarterly profitability, announced fresh client partnerships, and at the same time lowered its full year 2026 revenue guidance. See our latest analysis for Commerce.com. Commerce.com’s share price has fallen 29.1% over the past week and is down 45.3% year to date, while the 1-year total shareholder return has declined 49.1%. This suggests that recent earnings progress has not yet eased...
NasdaqGS:IART
NasdaqGS:IARTMedical Equipment

How Earnings Turnaround And FX-Hit Outlook At Integra LifeSciences (IART) Has Changed Its Investment Story

Integra LifeSciences Holdings Corporation reported past second-quarter 2026 results showing sales of US$418.76 million and net income of US$4.48 million, a shift from a large net loss a year earlier. The company also modestly reduced its full-year 2026 reported revenue outlook due to currency headwinds while reaffirming its organic revenue growth and adjusted EPS guidance, underscoring the effect of foreign exchange on reported performance. We’ll now examine how this earnings improvement,...
NYSE:UDR
NYSE:UDRResidential REITs

How Investors Are Reacting To UDR (UDR) Stronger Profit, Steady Revenue And Higher 2026 Earnings Guidance

In late July 2026, UDR, Inc. reported second-quarter 2026 results showing net income of US$69.04 million and basic earnings per share from continuing operations of US$0.21, both higher than the same period a year earlier, while revenue was broadly unchanged at about US$425.40 million. Alongside these results, UDR raised its full-year 2026 net income guidance per diluted share to a range of US$1.03 to US$1.11, signaling management’s increased confidence in the company’s earnings...
NYSE:CHWY
NYSE:CHWYSpecialty Retail

Chewy (CHWY) Faces Valuation Scrutiny, Is The Growth Story Enough?

Recent commentary around Chewy (CHWY) has sharpened focus on the stock’s valuation and profitability pressures, drawing fresh attention as investors weigh its mixed return history against ongoing interest in pet e commerce. See our latest analysis for Chewy. Chewy’s recent 1 month share price return of 12.69% and 7 day share price return of 4.12% suggest some momentum is returning, although the year to date share price return has declined 29.74% and the 5 year total shareholder return has...
NYSE:ETSY
NYSE:ETSYMultiline Retail

Etsy (ETSY) Could Be 12% Overvalued As Raised Outlook Fuels Rally

Why Etsy Stock Is Back in Focus After Q2 Earnings Etsy (ETSY) is in the spotlight after second quarter results on August 5, 2026, along with a raised full year outlook, a new US$2b share repurchase plan, and a workforce restructuring. See our latest analysis for Etsy. The recent Q2 report, higher full year outlook and new US$2b buyback have come alongside a strong run in Etsy's share price, with a 90 day share price return of 42.92% and a 1 year total shareholder return of 40.45%, while the 5...
NYSE:FBK
NYSE:FBKBanks

FB Financial (FBK) Stock Looks Cheap On Fair Value But Full On Earnings

FB Financial stock has delivered a strong 86.8% return over the past three years, while the latest Excess Returns intrinsic value estimate suggests the shares trade at a discount to fair value even though broader valuation checks lean cautious. That mix leaves investors weighing a stock that has already performed well against signals that it may still be pricing in a margin of safety. FB Financial's 86.8% return over three years points to a stock that has already rewarded shareholders and...
NYSE:KSS
NYSE:KSSMultiline Retail

Kohl's (KSS) Following Board Changes And What They Could Mean For Valuation

Boardroom Changes Put Kohl's Governance In Focus Kohl's (KSS) is back on investor radars after a boardroom reshuffle, with long serving director John E. Schlifske retiring as independent Chair and Wendy Arlin stepping into the role on July 28, 2026. The company also added experienced consumer brands executive Niren Chaudhary to its Board, giving investors fresh information to consider around governance, oversight and how board composition might influence future decisions at the retailer. See...
NYSE:HP
NYSE:HPEnergy Services

Helmerich & Payne (HP) After Its Q3 Beat And Outlook Lift, Is The Valuation Catching Up?

Helmerich & Payne (HP) drew fresh attention after reporting fiscal Q3 2026 results that came in above its own guidance, along with a higher full-year North America rig-count outlook and a continued focus on debt reduction. See our latest analysis for Helmerich & Payne. At a share price of $37.10, Helmerich & Payne has seen a 30 day share price return of 11.31% and a year to date share price return of 23.91%, while the 1 year total shareholder return of 122.62% contrasts with a modest 3 year...
NYSE:CSL
NYSE:CSLBuilding

Carlisle Companies (CSL) Could Be 6% Undervalued After Guidance Raise And Buyback Boost

Carlisle Companies dividend hike and guidance raise put capital returns in focus Carlisle Companies (CSL) has drawn fresh attention after reporting record second quarter results, raising full year revenue guidance to mid single digit growth and lifting its 2026 share repurchase target to $1.2b. At the same time, the Board approved a 14% increase in the regular quarterly dividend to $1.25 per share, or $5 on an annualized basis. The dividend is payable on September 1, 2026, to shareholders of...
NasdaqGS:QNST
NasdaqGS:QNSTInteractive Media and Services

QuinStreet (QNST) Posted Strong Results And Guidance, Is The Stock Still A Bargain?

Why QuinStreet’s latest earnings and M&A comments matter for investors QuinStreet (QNST) has put itself firmly on investors’ radars after reporting detailed fourth quarter and full year 2026 results, alongside new fiscal 2027 revenue guidance and fresh commentary on potential acquisitions. The company reported fourth quarter sales of US$373.88 million and net income of US$19.11 million. For the full 2026 fiscal year, sales were US$1.29b with net income of US$81.24 million, according to the...
NasdaqGM:ATRC
NasdaqGM:ATRCMedical Equipment

AtriCure (ATRC) Lifted Its Guidance, Is The Stock Fully Priced?

AtriCure (ATRC) has drawn investor attention after multiple insider share sales. This followed a quarter in which the company reported 13% second quarter revenue growth, a return to net income, and raised full year guidance. See our latest analysis for AtriCure. AtriCure’s recent insider sales come against a backdrop of strong share price momentum, with a 57.38% 90 day share price return and 20.74% 30 day share price return, while the 5 year total shareholder return is still down 43.49%. If...
NYSE:MD
NYSE:MDHealthcare

Pediatrix Medical Group (MD) Stock Seems Undervalued While Its 89% Return Raises Questions

Pediatrix Medical Group has delivered a strong 89.0% share price return over the past year, yet the stock still screens as cheap on several valuation checks. This raises the question of how much of the recent improvement is already reflected in the price. The recent share price drop following earnings news adds another layer for investors weighing whether the current level still offers value. Over the last 1 year, Pediatrix Medical Group shares are up 89.0%. This means anyone looking at the...